The Sherwin-Williams financials
$330.44−0.71%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.79B | $5.67B | $5.60B | $6.36B | $6.31B | $5.31B | $5.30B | $6.16B | $6.27B | $5.37B | $5.25B | $6.12B |
| Gross profit | $3.34B | $2.78B | $2.71B | $3.13B | $3.12B | $2.56B | $2.57B | $3.03B | $3.06B | $2.53B | $2.55B | $2.92B |
| Gross margin | 49.2% | 49.1% | 48.5% | 49.2% | 49.4% | 48.2% | 48.6% | 49.1% | 48.8% | 47.2% | 48.5% | 47.7% |
| Operating income | $1.23B | $804.6M | $775.8M | $1.17B | $1.10B | $756.4M | $690.3M | $1.13B | $1.22B | $729.2M | $641.7M | $1.10B |
| Net income | $843.6M | $534.7M | $476.8M | $833.1M | $754.7M | $503.9M | $480.1M | $806.2M | $889.9M | $505.2M | $356.2M | $761.5M |
| Net margin | 12.4% | 9.4% | 8.5% | 13.1% | 12.0% | 9.5% | 9.1% | 13.1% | 14.2% | 9.4% | 6.8% | 12.4% |
| Diluted EPS | $3.43 | $2.15 | $1.92 | $3.35 | $3.00 | $2.00 | $1.90 | $3.18 | $3.50 | $1.97 | $1.39 | $2.95 |
| EBITDA | $1.45B | $1.02B | $1.07B | $1.28B | $1.29B | $946.0M | $927.2M | $1.25B | $1.39B | $902.5M | $665.6M | $1.25B |
| Operating cash flow | $1.35B | $139.1M | $1.09B | $1.31B | $1.11B | -$61.1M | $934.5M | $1.07B | $1.20B | -$58.9M | $918.6M | $1.31B |
| Free cash flow | $1.24B | $800.0K | $862.1M | $1.11B | $931.1M | -$250.4M | $634.5M | $839.4M | $952.0M | -$342.7M | $599.1M | $1.16B |
| Diluted shares | 246.0M | 248.1M | 248.8M | 249.0M | 251.3M | 252.5M | 252.5M | 253.9M | 254.2M | 255.8M | 256.2M | 258.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $293.5M | $216.9M | $207.2M | $241.5M | $269.8M | $199.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $12.07B | $11.70B | $10.87B | $11.52B | $10.69B | $10.78B |
| Total assets | $26.95B | $26.38B | $25.90B | $26.21B | $25.36B | $24.64B |
| Total liabilities | $23.10B | $21.95B | $21.30B | $21.78B | $20.96B | $20.51B |
| Shareholders' equity | $3.85B | $4.43B | $4.60B | $4.43B | $4.40B | $4.13B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology